These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19103523)

  • 21. Down-regulation of urokinase plasminogen activator and matrix metalloproteinases and up-regulation of their inhibitors by a novel nutrient mixture in human prostate cancer cell lines PC-3 and DU-145.
    Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
    Oncol Rep; 2011 Dec; 26(6):1407-13. PubMed ID: 21874261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth of human prostate cancer cells is significantly suppressed in vitro with sodium butyrate through apoptosis.
    Qiu J; Gao Z; Shima H
    Oncol Rep; 2012 Jan; 27(1):160-7. PubMed ID: 21947091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiosensitization of hormone-refractory prostate cancer cells by gossypol treatment.
    Akagunduz O; Karaca B; Atmaca H; Uzunoglu S; Karabulut B; Sanli UA; Haydaroglu A; Uslu R
    J BUON; 2010; 15(4):763-7. PubMed ID: 21229643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human prostate cancer cells induce inflammatory cytokine secretion by peripheral blood mononuclear cells.
    Salman H; Ori Y; Bergman M; Djaldetti M; Bessler H
    Biomed Pharmacother; 2012 Jul; 66(5):330-3. PubMed ID: 22739042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
    Joseph IB; Isaacs JT
    Cancer Res; 1997 Mar; 57(6):1054-7. PubMed ID: 9067270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells.
    Aalinkeel R; Nair MP; Sufrin G; Mahajan SD; Chadha KC; Chawda RP; Schwartz SA
    Cancer Res; 2004 Aug; 64(15):5311-21. PubMed ID: 15289337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxicity of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone in androgen-dependent and -independent prostate cancer cell lines.
    Copeland RL; Das JR; Bakare O; Enwerem NM; Berhe S; Hillaire K; White D; Beyene D; Kassim OO; Kanaan YM
    Anticancer Res; 2007; 27(3B):1537-46. PubMed ID: 17595773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells.
    Liu T; Bauskin AR; Zaunders J; Brown DA; Pankhurst S; Russell PJ; Breit SN
    Cancer Res; 2003 Aug; 63(16):5034-40. PubMed ID: 12941831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptosis-mediated cytotoxic effects of ibandronic acid on hormone- and drug-refractory prostate cancer cells and human breast cancer cells.
    Kucukzeybek Y; Gorumlu G; Cengiz E; Karabulut B; Sezgin C; Atmaca H; Sanli UA; Uzunoglu S; Uslu R
    J Int Med Res; 2010; 38(5):1663-72. PubMed ID: 21309480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
    Uslu R; Borsellino N; Frost P; Gárban H; Ng CP; Mizutani Y; Belldegrun A; Bonavida B
    Clin Cancer Res; 1997 Jun; 3(6):963-72. PubMed ID: 9815772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells.
    Ferrer FA; Miller LJ; Andrawis RI; Kurtzman SH; Albertsen PC; Laudone VP; Kreutzer DL
    J Urol; 1997 Jun; 157(6):2329-33. PubMed ID: 9146665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of XTT and Alamar blue assays in the assessment of the viability of various human cancer cell lines by AT-101 (-/- gossypol).
    Uzunoglu S; Karaca B; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uslu R
    Toxicol Mech Methods; 2010 Oct; 20(8):482-6. PubMed ID: 20843265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression.
    Uzzo RG; Crispen PL; Golovine K; Makhov P; Horwitz EM; Kolenko VM
    Carcinogenesis; 2006 Oct; 27(10):1980-90. PubMed ID: 16606632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Taxol synergizes with antioxidants in inhibiting hormal refractory prostate cancer cell growth.
    Ping SY; Hour TC; Lin SR; Yu DS
    Urol Oncol; 2010; 28(2):170-9. PubMed ID: 18818108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apoptosis of human prostate androgen-dependent and -independent carcinoma cells induced by an isopropanolic extract of black cohosh involves degradation of cytokeratin (CK) 18.
    Hostanska K; Nisslein T; Freudenstein J; Reichling J; Saller R
    Anticancer Res; 2005; 25(1A):139-47. PubMed ID: 15816531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical studies of gossypol in prostate carcinoma.
    Naik H; Petrylak D; Yagoda A; Lehr J; Akhtar A; Pienta K
    Int J Oncol; 1995 Jan; 6(1):209-13. PubMed ID: 21556526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adrenomedullin prevents apoptosis in prostate cancer cells.
    Abasolo I; Montuenga LM; Calvo A
    Regul Pept; 2006 Jan; 133(1-3):115-22. PubMed ID: 16297990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.
    Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR
    Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor activity of the histone deacetylase inhibitor MS-275 in prostate cancer models.
    Qian DZ; Wei YF; Wang X; Kato Y; Cheng L; Pili R
    Prostate; 2007 Aug; 67(11):1182-93. PubMed ID: 17520666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.